Article FDA Thank You Leaders at FDA share highlights and updates for drugs and biologics at RAPS Convergence
Agency IQ
OCTOBER 12, 2023
Joneckis said that CBER has “some limited uses that we have seen in external submissions, mostly in the bioinformatics area,” but not as many as CDER. Regarding artificial intelligence (AI), an important topic at RAPS Convergence, the two centers discussed external and internal use cases.
Let's personalize your content